Medpace Holdings, Inc. - Common Stock (MEDP)

Historical Holders from Q3 2016 to Q4 2025

Type / Class
Equity / Common Stock
Symbol
MEDP on Nasdaq
Shares outstanding
28,414,670
Price per share
$561.65
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares as of 30 Sep 2025
23,962,504
Holdings value
$12,311,929,039
% of all portfolios
0.02%
Share change
-2,417,462
Value change
-$1,139,342,555
Average buys %
+0%
Average sells %
-0%
Number of holders
663
Price from insider filings
$107.93
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Medpace Holdings, Inc. - Common Stock (MEDP) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Troendle August J. 20% +2.5% $3,389,756,472 -$200,043,884 5,682,934 -5.6% August J. Troendle 26 Nov 2025
As of 30 Sep 2025, Medpace Holdings, Inc. - Common Stock (MEDP) has 663 institutional shareholders filing 13F forms. They hold 23,962,504 shares of 28,414,670 outstanding shares (84%) .

Top 25 institutional shareholders own 53% of the company.

Filer Ownership Nb Shares Share Change % Portfolio % Holdings Value
BlackRock, Inc. 8.3% 2,357,123 -4.4% 0.02% $1,211,938,483
VANGUARD GROUP INC 8% 2,282,972 -4.5% 0.02% $1,173,812,884
AQR CAPITAL MANAGEMENT LLC 3.6% 1,025,410 +65% 0.33% $518,170,435
WASATCH ADVISORS LP 3.3% 925,963 -2.1% 2.6% $476,093,136
STATE STREET CORP 2.4% 673,141 -4.8% 0.01% $346,102,177
Mawer Investment Management Ltd. 2.3% 646,774 -21% 1.7% $332,545,320
GEODE CAPITAL MANAGEMENT, LLC 2.3% 642,673 +0.74% 0.02% $330,473,022
D. E. Shaw & Co., Inc. 2.1% 600,140 +75% 0.25% $308,567,983
BAILLIE GIFFORD & CO 2.1% 584,796 +12% 0.22% $300,678,712
Invesco Ltd. 1.9% 537,407 +19% 0.04% $276,313,182
MORGAN STANLEY 1.8% 510,923 +4.6% 0.02% $262,697,261
RENAISSANCE TECHNOLOGIES LLC 1.7% 493,588 -27% 0.34% $253,783,206
DIMENSIONAL FUND ADVISORS LP 1.4% 388,058 -6.3% 0.04% $199,495,858
RIVERBRIDGE PARTNERS LLC 1.3% 365,088 -16% 3.2% $187,713,805
BESSEMER GROUP INC 1.2% 341,917 -33% 0.27% $175,800,000
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP 1.1% 314,150 +206% 0.1% $161,523,364
Findlay Park Partners LLP 1.1% 302,300 -1.7% 1.6% $155,430,568
Madison Asset Management, LLC 1% 292,629 -1.5% 1.7% $150,457,875
Giverny Capital Inc. 0.92% 261,802 +0.02% 4.6% $134,608,116
Clearbridge Investments, LLC 0.9% 256,564 -2.8% 0.1% $131,915,116
AMERICAN CAPITAL MANAGEMENT INC 0.88% 248,757 -6.3% 5.1% $127,900,899
UBS Group AG 0.87% 247,629 -9.5% 0.02% $127,320,927
NORTHERN TRUST CORP 0.85% 242,402 -28% 0.02% $124,633,412
BANK OF AMERICA CORP /DE/ 0.81% 229,353 +21% 0.01% $117,924,139
Vulcan Value Partners, LLC 0.7% 200,172 -30% 1.9% $103,241,211

Institutional Holders of Medpace Holdings, Inc. - Common Stock (MEDP) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q4 306,786 $173,611,913 +$36,950,182 $561.65 26
2025 Q3 23,962,504 $12,311,929,039 -$1,139,342,555 $514.16 663
2025 Q2 26,383,560 $8,288,435,409 +$333,924,717 $313.86 594
2025 Q1 25,343,081 $7,716,238,673 -$9,715,142 $304.69 576
2024 Q4 25,331,795 $8,417,259,527 +$78,993,016 $332.23 578
2024 Q3 25,078,556 $8,379,228,697 -$156,643,937 $333.80 576
2024 Q2 25,123,043 $10,346,630,119 +$74,318,631 $411.85 618
2024 Q1 24,952,951 $10,082,317,534 +$220,628,799 $404.15 584
2023 Q4 82,618 $25,359,626 +$11,291,032 $306.53 5
2023 Q3 23,796,843 $5,763,431,549 -$27,498,819 $242.13 477
2023 Q2 23,686,331 $5,688,939,821 -$272,260,092 $240.17 451
2023 Q1 24,850,086 $4,672,067,690 +$107,834,945 $188.05 408
2022 Q4 24,140,143 $5,127,902,204 -$275,370,306 $212.41 409
2022 Q3 25,720,926 $4,042,308,837 -$77,992,547 $157.17 334
2022 Q2 26,304,137 $3,926,446,107 -$149,862,394 $149.67 324
2022 Q1 27,262,176 $4,459,390,206 -$288,891,808 $163.59 331
2021 Q4 28,477,854 $6,196,066,680 -$16,366,403 $217.64 375
2021 Q3 28,611,077 $5,415,037,207 +$189,253,038 $189.28 330
2021 Q2 27,556,169 $4,867,256,718 -$59,750,344 $176.63 319
2021 Q1 27,974,530 $4,592,245,582 +$104,139,266 $164.05 313
2020 Q4 27,659,725 $3,848,156,121 +$92,415,519 $139.20 304
2020 Q3 26,856,323 $3,001,153,305 -$129,210,746 $111.75 302
2020 Q2 28,343,774 $2,635,284,602 +$18,280,774 $93.02 264
2020 Q1 28,126,126 $2,064,730,654 -$34,973,290 $73.38 260
2019 Q4 28,839,389 $2,418,322,620 +$12,861,008 $84.06 242
2019 Q3 28,494,699 $2,389,936,343 -$75,067,867 $84.04 258
2019 Q2 29,668,023 $1,923,105,392 +$236,417,964 $65.42 216
2019 Q1 27,098,751 $1,596,708,125 -$95,602,241 $58.97 224
2018 Q4 28,649,042 $1,505,488,597 +$237,400,235 $52.93 211
2018 Q3 24,075,036 $1,443,015,978 +$617,354,522 $59.91 205
2018 Q2 13,906,568 $597,916,964 +$189,676,125 $43.00 141
2018 Q1 9,415,446 $328,713,487 +$38,062,865 $34.91 108
2017 Q4 8,566,251 $303,468,112 +$73,429,567 $36.26 111
2017 Q3 6,389,162 $203,789,709 +$6,862,523 $31.90 84
2017 Q2 6,307,151 $182,910,653 -$10,958,173 $29.00 76
2017 Q1 6,616,348 $197,508,880 -$7,558,176 $29.85 76
2016 Q4 7,258,363 $261,791,100 +$49,003,112 $36.07 78
2016 Q3 6,172,151 $179,832,168 +$179,832,199 $29.86 68